1. Home
  2. AYTU vs LDTC Comparison

AYTU vs LDTC Comparison

Compare AYTU & LDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • LDTC
  • Stock Information
  • Founded
  • AYTU N/A
  • LDTC 2007
  • Country
  • AYTU United States
  • LDTC Canada
  • Employees
  • AYTU N/A
  • LDTC N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • LDTC Blank Checks
  • Sector
  • AYTU Health Care
  • LDTC Finance
  • Exchange
  • AYTU Nasdaq
  • LDTC Nasdaq
  • Market Cap
  • AYTU 10.7M
  • LDTC 9.4M
  • IPO Year
  • AYTU N/A
  • LDTC N/A
  • Fundamental
  • Price
  • AYTU $1.51
  • LDTC $0.30
  • Analyst Decision
  • AYTU
  • LDTC Buy
  • Analyst Count
  • AYTU 0
  • LDTC 3
  • Target Price
  • AYTU N/A
  • LDTC $1.00
  • AVG Volume (30 Days)
  • AYTU 45.2K
  • LDTC 173.7K
  • Earning Date
  • AYTU 11-13-2024
  • LDTC 08-14-2024
  • Dividend Yield
  • AYTU N/A
  • LDTC N/A
  • EPS Growth
  • AYTU N/A
  • LDTC N/A
  • EPS
  • AYTU N/A
  • LDTC N/A
  • Revenue
  • AYTU $79,759,000.00
  • LDTC $6,052,694.00
  • Revenue This Year
  • AYTU N/A
  • LDTC N/A
  • Revenue Next Year
  • AYTU $2.35
  • LDTC $2.28
  • P/E Ratio
  • AYTU N/A
  • LDTC N/A
  • Revenue Growth
  • AYTU N/A
  • LDTC 2.76
  • 52 Week Low
  • AYTU $1.41
  • LDTC $0.22
  • 52 Week High
  • AYTU $3.45
  • LDTC $11.20
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 26.32
  • LDTC 52.73
  • Support Level
  • AYTU $1.41
  • LDTC $0.29
  • Resistance Level
  • AYTU $1.63
  • LDTC $0.37
  • Average True Range (ATR)
  • AYTU 0.21
  • LDTC 0.04
  • MACD
  • AYTU -0.01
  • LDTC 0.00
  • Stochastic Oscillator
  • AYTU 11.98
  • LDTC 52.89

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About LDTC LeddarTech Holdings Inc.

LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation.

Share on Social Networks: